Literature DB >> 33961783

Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.

Milena Hornburg1, Mélanie Desbois2, Shan Lu2, Yinghui Guan2, Amy A Lo3, Susan Kaufman4, Ashley Elrod5, Alina Lotstein5, Teresa M DesRochers5, Jose L Munoz-Rodriguez6, Xingwei Wang7, Jennifer Giltnane3, Oleg Mayba1, Shannon J Turley8, Richard Bourgon1, Anneleen Daemen1, Yulei Wang9.   

Abstract

Distinct T cell infiltration patterns, i.e., immune infiltrated, excluded, and desert, result in different responses to cancer immunotherapies. However, the key determinants and biology underpinning these tumor immune phenotypes remain elusive. Here, we provide a high-resolution dissection of the entire tumor ecosystem through single-cell RNA-sequencing analysis of 15 ovarian tumors. Immune-desert tumors are characterized by unique tumor cell-intrinsic features, including metabolic pathways and low antigen presentation, and an enrichment of monocytes and immature macrophages. Immune-infiltrated and -excluded tumors differ markedly in their T cell composition and fibroblast subsets. Furthermore, our study reveals chemokine receptor-ligand interactions within and across compartments as potential mechanisms mediating immune cell infiltration, exemplified by the tumor cell-T cell cross talk via CXCL16-CXCR6 and stromal-immune cell cross talk via CXCL12/14-CXCR4. Our data highlight potential molecular mechanisms that shape the tumor immune phenotypes and may inform therapeutic strategies to improve clinical benefit from cancer immunotherapies.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCL16; Granzyme K; desert; excluded; fibroblasts; immune phenotype; infiltrated; ovarian cancer; single-cell RNA-seq; tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 33961783     DOI: 10.1016/j.ccell.2021.04.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  37 in total

Review 1.  Precision medicine in rheumatoid arthritis.

Authors:  Kartik Bhamidipati; Kevin Wei
Journal:  Best Pract Res Clin Rheumatol       Date:  2022-03-02       Impact factor: 4.098

2.  Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.

Authors:  Adrienne M Luoma; Shengbao Suo; Yifan Wang; Lauren Gunasti; Caroline B M Porter; Nancy Nabilsi; Jenny Tadros; Andrew P Ferretti; Sida Liao; Cagan Gurer; Yu-Hui Chen; Shana Criscitiello; Cora A Ricker; Danielle Dionne; Orit Rozenblatt-Rosen; Ravindra Uppaluri; Robert I Haddad; Orr Ashenberg; Aviv Regev; Eliezer M Van Allen; Gavin MacBeath; Jonathan D Schoenfeld; Kai W Wucherpfennig
Journal:  Cell       Date:  2022-07-07       Impact factor: 66.850

Review 3.  Cancer-associated fibroblasts in the single-cell era.

Authors:  Dor Lavie; Aviad Ben-Shmuel; Neta Erez; Ruth Scherz-Shouval
Journal:  Nat Cancer       Date:  2022-07-26

Review 4.  Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation.

Authors:  Lana E Kandalaft; Denarda Dangaj Laniti; George Coukos
Journal:  Nat Rev Cancer       Date:  2022-09-15       Impact factor: 69.800

5.  Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer.

Authors:  Huocong Huang; Zhaoning Wang; Yuqing Zhang; Rachana N Pradhan; Debolina Ganguly; Raghav Chandra; Gilbert Murimwa; Steven Wright; Xiaowu Gu; Ravikanth Maddipati; Sören Müller; Shannon J Turley; Rolf A Brekken
Journal:  Cancer Cell       Date:  2022-05-05       Impact factor: 38.585

Review 6.  The STING pathway: Therapeutic vulnerabilities in ovarian cancer.

Authors:  Noor Shakfa; Deyang Li; Sarah Nersesian; Juliette Wilson-Sanchez; Madhuri Koti
Journal:  Br J Cancer       Date:  2022-04-05       Impact factor: 9.075

7.  Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer.

Authors:  Huicheng Liu; Lili Bai; Liu Huang; Na Ning; Lin Li; Yijia Li; Xuejiao Dong; Qiuyang Du; Minghui Xia; Yufei Chen; Likun Zhao; Yanhu Li; Qingwu Meng; Jing Wang; Yaqi Duan; Jie Ming; Andy Qingan Yuan; Xiang-Ping Yang
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

8.  The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer.

Authors:  Yuri Belotti; Elaine Hsuen Lim; Chwee Teck Lim
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

Review 9.  Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.

Authors:  Elena Anghileri; Monica Patanè; Natalia Di Ianni; Irene Sambruni; Martina Maffezzini; Micaela Milani; Luisa Maddaloni; Bianca Pollo; Marica Eoli; Serena Pellegatta
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

Review 10.  Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Xin Luo; Jing Xu; Jianhua Yu; Ping Yi
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.